Osteomesh Series - Bone matrix implant, synthetic

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Osteopore Australasia Pty Ltd

Classe:

Class III

Prodotto da:

Osteopore International Pte Ltd 2 Tukang Innovation Grove, 09-06 MedTech Hub, Singapore, 618305 Singapore

Area terapeutica:

17751 - Bone matrix implant, synthetic

Indicazioni terapeutiche:

Osteomesh is a sterile mesh scaffold bone void filler used to fill cranial defects. It is rectangular in shape. It conforms to the shape of the defect thus maximising direct contact with the viable bone host. It is made of polycaprolactone which degrades and resorbs fully in vivo by hydrolysis, then is metabolised by the body. This will occur over a period of 18-24 months. Osteomesh? is a bone void filler. It is indicated for the repair of orbital floor fractures. The shape of the Osteomesh conforms to the defect, thus maximising direct contact with the viable bone host.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2020-04-15